Anavex Life Sciences Corp (AVXL)

[vg_future]

To be clear, there will be additional details from RETT and PDD in early 2021. Not sure actigraphy or something else...from the CC transcript see below.

Dr. Christopher Missling

Yeah. So we want to be very transparent, and we will, you have to appreciate that the primary endpoint of both studies and secondary the efficacy endpoints will also looking at a genetic outcome of the patient genetic background of the patient. And that requires a bit more time than usually analysis of studies. That's why we have to basically go through this before we can basically submit this to a publication, but we mentioned that we will submit to a publication the [PDD] studies and will present probably over the course of early 2021 more details about the PDD study as well as the Rett study

vg_future